MCC-135 as Adjunct Therapy to Primary Percutaneous Coronary Intervention in ST-Segment Elevation Acute Myocardial Infarction Patients

This study has been completed.

Sponsor:

Information provided by:

Mitsubishi Tanabe Pharma Corporation

ClinicalTrials.gov Identifier:

NCT00078013

First received: February 13, 2004

Last updated: June 23, 2005

Last verified: March 2005

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been completed.
Estimated Study Completion Date:	August 2004
Estimated Primary Completion Date:	No date given